Literature DB >> 28888714

The Diagnosis and Management of Bipolar I and II Disorders: Clinical Practice Update.

William V Bobo1.   

Abstract

Bipolar disorders, including bipolar I disorder (BP-I) and bipolar II disorder (BP-II), are common, potentially disabling, and, in some cases, life-threatening conditions. Bipolar disorders are characterized by alternating episodes of mania or hypomania and depression, or mixtures of manic and depressive features. Bipolar disorders present many diagnostic and therapeutic challenges for busy clinicians. Adequate management of bipolar disorders requires pharmacotherapy and psychosocial interventions targeted to the specific phases of illness. Effective treatments are available for each illness phase, but mood episode relapses and incomplete responses to treatment are common, especially for the depressive phase. Mood symptoms, psychosocial functioning, and suicide risk must, therefore, be continually reevaluated, and, when necessary, the plan of care must be adjusted during long-term treatment. Many patients will require additional treatment of comorbid psychiatric and substance use disorders and management of a variety of commonly co-occurring chronic general medical conditions.
Copyright © 2017 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 28888714     DOI: 10.1016/j.mayocp.2017.06.022

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  9 in total

1.  The Neurobiology of Bipolar Disorder.

Authors:  Allan H Young; Mario F Juruena
Journal:  Curr Top Behav Neurosci       Date:  2021

Review 2.  Lamotrigine in the maintenance treatment of bipolar disorder.

Authors:  Yasuhiko Hashimoto; Kazumasa Kotake; Norio Watanabe; Takashi Fujiwara; Shinji Sakamoto
Journal:  Cochrane Database Syst Rev       Date:  2021-09-15

Review 3.  Inflaming sex differences in mood disorders.

Authors:  Jennifer R Rainville; Georgia E Hodes
Journal:  Neuropsychopharmacology       Date:  2018-06-19       Impact factor: 7.853

Review 4.  Cariprazine to Treat Schizophrenia and Bipolar Disorder in Adults.

Authors:  Amber Edinoff; Miriam T Ruoff; Yahya T Ghaffar; Arthur Rezayev; Devanshi Jani; Adam M Kaye; Elyse M Cornett; Alan D Kaye; Omar Viswanath; Ivan Urits
Journal:  Psychopharmacol Bull       Date:  2020-09-14

Review 5.  Pharmacogenomic Characterization in Bipolar Spectrum Disorders.

Authors:  Stefano Fortinguerra; Vincenzo Sorrenti; Pietro Giusti; Morena Zusso; Alessandro Buriani
Journal:  Pharmaceutics       Date:  2019-12-21       Impact factor: 6.321

Review 6.  Comorbid Premenstrual Dysphoric Disorder in Women with Bipolar Disorder: Management Challenges.

Authors:  Gianna Sepede; Marcella Brunetti; Massimo Di Giannantonio
Journal:  Neuropsychiatr Dis Treat       Date:  2020-02-10       Impact factor: 2.570

7.  Is aripiprazole similar to quetiapine for treatment of bipolar depression? Results from meta-analysis of Chinese data.

Authors:  Hejian Tao; Jiawei Wang; Dong Shen; Fengli Sun; Weidong Jin
Journal:  Front Psychiatry       Date:  2022-09-09       Impact factor: 5.435

Review 8.  Real-World Patterns of Utilization and Costs Associated with Second-Generation Oral Antipsychotic Medication for the Treatment of Bipolar Disorder: A Literature Review.

Authors:  Michael J Doane; Kristine Ogden; Leona Bessonova; Amy K O'Sullivan; Mauricio Tohen
Journal:  Neuropsychiatr Dis Treat       Date:  2021-02-16       Impact factor: 2.570

9.  The Effect of Organic Lithium Salts on Plasma 8-Hydroxy-2'-Deoxyguanosine in Bipolar Patients In Vitro.

Authors:  Prokopieva Valentina; Yarygina Ekaterina; Bokhan Nikolay; Plotnikov Evgenii
Journal:  Psychopharmacol Bull       Date:  2020-03-12
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.